The 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis: Updating the Modified Duke Criteria

  • Vance G Fowler
    Division of Infectious Diseases, Duke University Medical Center , Durham, North Carolina , USA
  • David T Durack
    Division of Infectious Diseases, Duke University Medical Center , Durham, North Carolina , USA
  • Christine Selton-Suty
    CHU of Nancy, Cardiology Department, CIC-EC , Nancy , France
  • Eugene Athan
    Department of Infectious Disease, Barwon Health and School of Medicine, Deakin University , Geelong , Australia
  • Arnold S Bayer
    Division of Infectious Diseases, The Lundquist Institute at Harbor-UCLA , Torrance, California , USA
  • Anna Lisa Chamis
    Division of Infectious Diseases, Duke University Medical Center , Durham, North Carolina , USA
  • Anders Dahl
    Department of Cardiology, Herlev-Gentofte University Hospital , Copenhagen , Denmark
  • Louis DiBernardo
    Division of Infectious Diseases, Duke University Medical Center , Durham, North Carolina , USA
  • Emanuele Durante-Mangoni
    Department of Precision Medicine, University of Campania ‘L. Vanvitelli’, Monaldi Hospital , Naples , Italy
  • Xavier Duval
    AP-HP, Hôpital Bichat, Centre d'Investigation Clinique, INSERM CIC 1425, Université Paris Cité, IAME, INSERM , Paris , France
  • Claudio Querido Fortes
    Infectious Diseases Department, Hospital Universitário Clementino Fraga Filho—Universidade Federal do Rio de Janeiro , Rio de Janeiro, Brasil
  • Emil Fosbøl
    The Heart Centre, University Hospital of Copenhagen , Rigshospitalet , Denmark
  • Margaret M Hannan
    Clinical Microbiology Department, Mater Misericordiae University Hospital, University College Dublin , Dublin , Ireland
  • Barbara Hasse
    Department of Infectious Diseases and Hospital Epidemiology, University Hospital, University of Zurich , Zurich , Switzerland
  • Bruno Hoen
    Department of Infectious Diseases and Tropical Medicine and Inserm CIC-1424, Université de Lorraine, APEMAC , Nancy , France
  • Adolf W Karchmer
    Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School , Boston, Massachusetts , USA
  • Carlos A Mestres
    Department of Cardiothoracic Surgery and the Robert WM Frater Cardiovascular Research Centre, The University of the Free State , Bloemfontein , South Africa
  • Cathy A Petti
    Division of Infectious Diseases, Duke University Medical Center , Durham, North Carolina , USA
  • María Nazarena Pizzi
    Department of Cardiology, Hospital Universitari Vall d’Hebron , Barcelona , Spain
  • Stephen D Preston
    Histopathology, Royal Papworth Hospital , Cambridge , United Kingdom
  • Albert Roque
    Department of Radiology, Hospital Universitari Vall d’Hebron , Barcelona , Spain
  • Francois Vandenesch
    CIRI, Centre International de Recherche en Infectiologie, Univ Lyon, INSERM, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon , Lyon , France
  • Jan T M van der Meer
    Division of Infectious Diseases, Amsterdam UMC , Amsterdam , The Netherlands
  • Thomas W van der Vaart
    Division of Infectious Diseases, Amsterdam UMC , Amsterdam , The Netherlands
  • Jose M Miro
    Infectious Diseases Service, Hospital Clinic-IDIBAPS, University of Barcelona , Barcelona , Spain

この論文をさがす

説明

<jats:title>Abstract</jats:title> <jats:p>The microbiology, epidemiology, diagnostics, and treatment of infective endocarditis (IE) have changed significantly since the Duke Criteria were published in 1994 and modified in 2000. The International Society for Cardiovascular Infectious Diseases (ISCVID) convened a multidisciplinary Working Group to update the diagnostic criteria for IE. The resulting 2023 Duke-ISCVID IE Criteria propose significant changes, including new microbiology diagnostics (enzyme immunoassay for Bartonella species, polymerase chain reaction, amplicon/metagenomic sequencing, in situ hybridization), imaging (positron emission computed tomography with 18F-fluorodeoxyglucose, cardiac computed tomography), and inclusion of intraoperative inspection as a new Major Clinical Criterion. The list of “typical” microorganisms causing IE was expanded and includes pathogens to be considered as typical only in the presence of intracardiac prostheses. The requirements for timing and separate venipunctures for blood cultures were removed. Last, additional predisposing conditions (transcatheter valve implants, endovascular cardiac implantable electronic devices, prior IE) were clarified. These diagnostic criteria should be updated periodically by making the Duke-ISCVID Criteria available online as a “Living Document.”</jats:p>

収録刊行物

被引用文献 (1)*注記

もっと見る

問題の指摘

ページトップへ